Cargando…

Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19

Detalles Bibliográficos
Autores principales: Rubattu, Speranza, Gallo, Giovanna, Volpe, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728735/
https://www.ncbi.nlm.nih.gov/pubmed/33330677
http://dx.doi.org/10.3389/fcvm.2020.616564
_version_ 1783621333697953792
author Rubattu, Speranza
Gallo, Giovanna
Volpe, Massimo
author_facet Rubattu, Speranza
Gallo, Giovanna
Volpe, Massimo
author_sort Rubattu, Speranza
collection PubMed
description
format Online
Article
Text
id pubmed-7728735
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77287352020-12-15 Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 Rubattu, Speranza Gallo, Giovanna Volpe, Massimo Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2020-11-27 /pmc/articles/PMC7728735/ /pubmed/33330677 http://dx.doi.org/10.3389/fcvm.2020.616564 Text en Copyright © 2020 Rubattu, Gallo and Volpe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Rubattu, Speranza
Gallo, Giovanna
Volpe, Massimo
Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
title Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
title_full Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
title_fullStr Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
title_full_unstemmed Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
title_short Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
title_sort sacubitril/valsartan: potential impact of arni “beyond the wall” of ace2 on treatment and prognosis of heart failure patients with coronavirus disease-19
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728735/
https://www.ncbi.nlm.nih.gov/pubmed/33330677
http://dx.doi.org/10.3389/fcvm.2020.616564
work_keys_str_mv AT rubattusperanza sacubitrilvalsartanpotentialimpactofarnibeyondthewalloface2ontreatmentandprognosisofheartfailurepatientswithcoronavirusdisease19
AT gallogiovanna sacubitrilvalsartanpotentialimpactofarnibeyondthewalloface2ontreatmentandprognosisofheartfailurepatientswithcoronavirusdisease19
AT volpemassimo sacubitrilvalsartanpotentialimpactofarnibeyondthewalloface2ontreatmentandprognosisofheartfailurepatientswithcoronavirusdisease19